ERBB2 and breast carcinoma: In a study conducted on 350 female canines with mammary carcinoma, 267 (76.3%) were classified as triple-negative, 50 (14.3%) as luminal A and 33 (9.4%) as luminal B. No HER-2-+ cases were detected [9].